Corient Private Wealth LP Makes New $1.14 Million Investment in Nutex Health Inc. $NUTX

Corient Private Wealth LP acquired a new stake in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 6,684 shares of the company's stock, valued at approximately $1,142,000. Corient Private Wealth LP owned approximately 0.10% of Nutex Health at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in NUTX. Kilter Group LLC acquired a new position in Nutex Health in the 2nd quarter worth about $27,000. Islay Capital Management LLC acquired a new stake in Nutex Health in the fourth quarter worth $34,000. Allworth Financial LP bought a new stake in Nutex Health in the 2nd quarter valued at about $35,000. BNP Paribas Financial Markets increased its holdings in shares of Nutex Health by 966.7% during the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company's stock valued at $40,000 after acquiring an additional 290 shares in the last quarter. Finally, Royal Bank of Canada increased its stake in Nutex Health by 752.4% during the 4th quarter. Royal Bank of Canada now owns 358 shares of the company's stock valued at $59,000 after purchasing an additional 316 shares in the last quarter. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on NUTX. B Riley reiterated a "buy" rating on shares of Nutex Health in a report on Friday. Wall Street Zen lowered Nutex Health from a "buy" rating to a "hold" rating in a report on Saturday. Lake Street Capital reaffirmed a "buy" rating and issued a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. B. Riley Financial upped their price objective on Nutex Health from $290.00 to $325.00 and gave the company a "buy" rating in a research note on Friday. Finally, Zacks Research upgraded shares of Nutex Health from a "hold" rating to a "strong-buy" rating in a research note on Monday, August 24th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $317.50.

Nutex Health Trading Down 2.2%

NUTX stock opened at $193.24 on Friday. The company has a market capitalization of $1.32 billion, a PE ratio of 7.59 and a beta of 0.28. The company's 50 day moving average price is $175.59 and its two-hundred day moving average price is $136.75. Nutex Health Inc. has a one year low of $80.53 and a one year high of $204.00. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.95 by $4.43. The business had revenue of $210.75 million during the quarter, compared to analyst estimates of $215.03 million. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%.

Nutex Health Profile

Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

Want to see what other hedge funds are holding NUTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutex Health Inc. (NASDAQ:NUTX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source